Articles by Nicky Toor

Nicky graduated with a BA in Journalism and a Minor in English from Kwantlen Polytechnic University. She has written on a variety of different topics including fashion, beauty, entertainment and finance. Her favourite things to do are travel (when she can) and to spend time with friends and family, including her dog Kobe.

Celldex Shares Fall Over 60% After Failed Drug Study

Apr 16 Nicky Toor

Shares of the biotechnology company Celldex Therapeutics Inc. (NASDAQ:CLDX) have fallen over 60% today after the company announced that its study in Metastatic Triple-negative Breast Cancer failed to reach the targeted endpoint. The phase 2b ... [Read]

Essendant Inc to Merge With Genuine Parts Co. – Shares Jump

Apr 13 Nicky Toor

Shares of the equipment company Essendant Inc. (NASDAQ:ESND) jumped by over 20% after the company announced today that they would be merging with Genuine Parts Company’s (NYSE:GPC) S.P. Richards business. According to the company’s release, ... [Read]

Tandem Diabetes Care Shares Surged Up Over 20%

Apr 10 Nicky Toor

Shares of the medical device and manufacturing company Tandem Diabetes Care (NASDAQ:TNDM) surged up over 20% today. The rise in share value can be attributed to the company releasing their preliminary first quarter 2018 results. ... [Read]

Verastem Inc Shares Rise – New Drug Application Accepted by FDA

Apr 10 Nicky Toor

Shares of the biopharmaceutical company Verastem Inc. (NASDAQ:VSTM) were on the rise on Monday after the company announced that the United States Food and Drug Administration (FDA) had accepted their New Drug Application (NDA) for ... [Read]

Turtle Beach Corporation Shares Up Over 35%

Apr 9 Nicky Toor

Shares of the San Diego-based gaming headset and audio accessory company, Turtle Beach Corporation (Nasdaq:HEAR) have gone up by over 35% today. The jump in share value comes after the company released its preliminary first-quarter ... [Read]

Shares of Menlo Therapeutics Plummet By 70%

Apr 9 Nicky Toor

Shares of the biopharmaceutical company Menlo Therapeutics Inc. (Nasdaq:MNLO) have plummeted by nearly 70%. The loss of share value is due to the company releasing the results of their Phase 2 Trial of ‘Serlopitant’ for ... [Read]

EyeGate Pharmaceuticals – Stock Up Nearly 25%

Apr 6 Nicky Toor

Shares of Massachusetts-based EyeGate Pharmaceuticals (Nasdaq:EYEG) have gone up nearly 25% after the company announced the enrollment confirmation of the Phase 3 Clinical Study of EGP-437 in Anterior Uveitis. The trial is meant “to assess ... [Read]

Conn’s Inc Stock Takes a Tumble After Q4 Results

Apr 5 Nicky Toor

Shares of the Texas-based home-furnishings and consumer electronics retail store Conn’s (Nasdaq:CONN) have gone tumbling down today after releasing their fourth quarter financial results. >>>Disappointing Fourth Quarter Results for Hudson’s Bay Company The results showed ... [Read]

Conatus Pharmaceuticals Failed Clinical Trial

Conatus Pharmaceuticals Shares Dive After Failed Clinical Trial

Apr 5 Nicky Toor

Shares of Conatus Pharmaceuticals (Nasdaq:CNAT) have taken a dive, dropping over 30%, after releasing the results from their Phase 2b clinical trial. The POLT-HCV-SVR clinical trial, which studied emiscaran in liver transplant patients with fibrosis ... [Read]

Sonoma Pharmaceuticals FDA Approval – Shares Soar

Apr 5 Nicky Toor

California-based Sonoma Pharmaceuticals (Nasdaq:SNOA) has received approval from the US Food and Drug Administration (FDA) for their antimicrobial post-therapy gel. Shares of the company soared this morning after the announcement and, currently, the high for ... [Read]